Acción 2289 CHARMACY PHARMACEUTICAL CO., LTD.
Añadir a una lista
Para utilizar esta función debe ser un cliente o miembro.
ConéctateRegístrate

Otros idiomas Charmacy Pharmaceutical Co., Ltd.

Acciones

2289

CNE1000023D6

Mercado cerrado - Hong Kong S.E.
Otros sitios de cotización
 10:08:22 10/05/2024 		Varia. Cinco días. Varia. 1 de enero.
13,88 HKD -0,14 % Gráfico intradía de Charmacy Pharmaceutical Co., Ltd. -0,72 % +7,10 %
28/03 Charmacy Pharmaceutical Co. Ltd. presenta los resultados del ejercicio finalizado el 31 de diciembre de 2023 CI
18/03 El beneficio de Charmacy Pharmaceutical caerá un 45% en 2023 MT

Otros idiomas

Buscar
Ver los resultados
Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!
Inscripción 100% Gratuita
Charmacy Pharmaceutical 2023 Profit Declines on Lower Asset Disposal Gains
Charmacy Pharmaceutical Co., Ltd. Proposes Final Dividend for the Year Ended 31 December 2023, Payable on 10 July 2024
Charmacy Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
Charmacy Pharmaceutical’s Profit to Drop by 45% in 2023
Charmacy Pharmaceutical Meets Minimum Public Float Norms
Charmacy Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023
Charmacy Pharmaceutical Co., Ltd. Approves Final Dividend for the Year Ended 31 December 2022, Payable on 31 July 2023
Charmacy Pharmaceutical Chairman Steps Down
Charmacy Pharmaceutical Co., Ltd. Announces Board Changes
Charmacy Pharmaceutical Co., Ltd. Announces Ordinary Final Dividend for the Year Ended 31 December 2022, Payable on July 31, 2023
Charmacy Pharmaceutical's Controlling Shareholder Signs Letter of Commitment for Director Appointment; Shares Climb 6%
Charmacy Pharmaceutical Co., Ltd. Announces Resignation of Executives
Charmacy Pharmaceutical Co., Ltd. Recommends Ordinary Final Dividend for the Year Ended 31 December 2022, Payable on 20 July 2023
Charmacy Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
Charmacy Pharmaceutical Renews Loan Provision Deal with Controlling Shareholder
Jiangxi Jiangzhong Pharmaceutical Commercial Operation Co., Ltd. completed the acquisition of 32.12963% stake in Charmacy Pharmaceutical Co., Ltd. from a group of shareholders.
Jiangxi Jiangzhong Pharmaceutical Commercial Operation Co., Ltd. completed the acquisition of 9% of stake in Charmacy Pharmaceutical Co., Ltd. from Yao Chuanglong.
Jiangxi Jiangzhong Pharmaceutical Commercial Operation Co., Ltd. made an offer to acquire additional 32.12963% stake in Charmacy Pharmaceutical Co., Ltd. from a group of shareholders for approximately HKD 250 million.
Charmacy Pharmaceutical Forecasts Increase in January-November Net Profit
Charmacy Pharmaceutical Co., Ltd. Provides Financial Guidance for the 11 Months Ended 30 November 2022
No hay resultados para esta búsqueda
Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Filtros

Buscar

Fecha de publicación

De

Hasta

  1. Bolsa de valores
  2. Acciones
  3. Acción 2289
  4. Noticias Charmacy Pharmaceutical Co., Ltd.
  5. Otros idiomas